Certificate of Analysis
HEMP QUALITY ASSURANCE TEST

Sample Name:

Water Soluble D9 09/05/2024

Infused, Non-Inhalable

Date Issued:

09/10/2024

Total THC 106.607 mg/g
Total CBD 1.266 mg/g
Sum Cannabinoids 114.375 mg/g
Total Cannabinoids 114.375 mg/g

Sample Information

Sample Details

Sample ID:240909K006

Batch Number:WS.D9.090524

Cultivator / Manufacturer

Show Details

Distributor / Tested For

Show Details

Share

Easily share a link to this results page with your friends, followers, or business partners.

Cannabinoid Analysis - Summary

Total THC: 106.607 mg/g

Total CBD: 1.266 mg/g

Sum of Cannabinoids: 114.375 mg/g

Total Cannabinoids: 114.375 mg/g

Density:1.0027 g/mL

Total THC/CBD is calculated using the following formulas to take into account the loss of a carboxyl group during the decarboxylation step:
Total THC = Δ9-THC + (THCa (0.877))
Total CBD = CBD + (CBDa (0.877))

Sum of Cannabinoids = Δ9-THC + THCa + CBD + CBDa + CBG + CBGa + THCV + THCVa + CBC + CBCa + CBDV + CBDVa + Δ8-THC + CBL + CBN

Total Cannabinoids = (Δ9-THC+0.877*THCa) + (CBD+0.877*CBDa) + (CBG+0.877*CBGa) + (THCV+0.877*THCVa) + (CBC+0.877*CBCa) + (CBDV+0.877*CBDVa) + Δ8-THC + CBL + CBN

Sum of Cannabinoids: The concentration of each individual cannabinoid added together as they are, without accounting for decarboxylation. This measurement is of particular importance for certain cannabis products that are not intended to be heated prior to application or consumption.

Total Cannabinoids: The concentration of each acidic cannabinoid, multiplied by 0.877 to account for the loss of molecular mass that happens as it is converted to a neutral cannabinoid when heated. Then this calculated concentration is added to the concentrations of the corresponding neutral cannabinoid already present. This corrected data is of particular importance to both producers and consumers of products intended to be heated prior to application or consumption.

View Complete Test Results:

Tested by high-performance liquid chromatography with diode-array detection (HPLC-DAD).

Method: QSP 1157 - Analysis of Cannabinoids by HPLC-DAD

Summary

Total THC: 106.607 mg/g

(Δ9-THC+0.877*THCa)

Total CBD: 1.266 mg/g

(CBD+0.877*CBDa)

Total Cannabinoids: 114.375 mg/g

Total CBG: 3.241 mg/g

Total CBG (CBG+0.877*CBGa)

Total THCV: 0.516 mg/g

Total THCV (THCV+0.877*THCVa)

Total CBC: 0.664 mg/g

Total CBC (CBC+0.877*CBCa)

Total CBDV: ND

Total CBDV (CBDV+0.877*CBDVa)

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Cannabinoid Test Results

09/10/2024

Result Views

Swipe left on table to see additional columns

Compound LOD/LOQ
(mg/g)
Measurement
Uncertainty
(mg/g)
Result
(mg/g)
Result
(%)
Δ9 Tetrahydrocannabinol (Δ9THC) 0.002 / 0.014 ±5.8527 106.607 10.6607
Cannabigerol (CBG) 0.002 / 0.006 ±0.1572 3.241 0.3241
Cannabinol (CBN) 0.001 / 0.007 ±0.0597 2.081 0.2081
Cannabidiol (CBD) 0.004 / 0.011 ±0.0472 1.266 0.1266
Cannabichromene (CBC) 0.003 / 0.010 ±0.0214 0.664 0.0664
Tetrahydrocannabivarin (THCV) 0.002 / 0.012 ±0.0253 0.516 0.0516
Cannabicyclol (CBL) 0.003 / 0.010 N/A ND ND
Cannabichromenic Acid (CBCa) 0.001 / 0.015 N/A ND ND
Cannabidivarin (CBDV) 0.002 / 0.012 N/A ND ND
Cannabidiolic Acid (CBDa) 0.001 / 0.026 N/A ND ND
Cannabigerolic Acid (CBGa) 0.002 / 0.007 N/A ND ND
Tetrahydrocannabinolic Acid (THCa) 0.001 / 0.005 N/A ND ND
Cannabidivarinic Acid (CBDVa) 0.001 / 0.018 N/A ND ND
Tetrahydrocannabivarinic Acid (THCVa) 0.002 / 0.019 N/A ND ND
∆8 Tetrahydrocannabinol (Δ8THC) 0.01 / 0.02 N/A ND ND
SUM OF CANNABINOIDS 114.375 mg/g 11.4375%
Density Test Result

1.0027 g/mL Tested 09/10/2024 Method: QSP 7870 - Sample Preparation

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.